There are also isolated reports of the appearance of neuromotor abnormalities such as dystonia, chorea, myorhythmia, and Parkinson’s disease in patients treated with native or pegylated IFNα [116,117]. The gene discussed is IFNA1; the disease is Parkinson disease.